Oxazinanes
Medchemexpress LLC 3-Amino-2-oxazolidinone | 80-65-9 | 98.0% | 102.09 | 10 MG
3-Amino-2-oxazolidinone (AOZ) is a metabolite of Furazolidone used as an indicator for furazolidone residues in vivo. It is orally active and inhibits monoamine oxidase (MAO), increasing monoamine neurotransmitter levels in the brain and lowering blood pressure.
- Used as an indicator for furazolidone residues
- Orally active
- Inhibits monoamine oxidase (MAO)
- Increases levels of monoamine neurotransmitters
- Lowers blood pressure in renal hypertensive rats
Medchemexpress LLC 3-Amino-2-oxazolidinone | 80-65-9 | 98.0% | 102.09 | 5 MG
3-Amino-2-oxazolidinone (AOZ) is a metabolite of Furazolidone. It is used as an indicator for furazolidone residues in vivo and is orally active. It inhibits monoamine oxidase (MAO) via its metabolite in rat brain and liver. It also increases levels of monoamine neurotransmitters (such as norepinephrine and dopamine) in the brain and lowers blood pressure in renal hypertensive rats.
- Metabolite of furazolidone.
- Always detected as an indicator of furazolidone residues in vivo.
- Orally active.
- Inhibits monoamine oxidase (MAO) via its metabolite in rat brain and liver.
- Increases levels of monoamine neurotransmitters (such as norepinephrine and dopamine) in the brain.
- Lowers blood pressure in renal hypertensive rats.
Medchemexpress LLC 3-Amino-2-oxazolidinone | 80-65-9 | MFCD00020871 | 98.0% | 102.09 | 1 ML
3-Amino-2-oxazolidinone (AOZ) is a metabolite of Furazolidone. It is consistently detected as an indicator of furazolidone residues in vivo. This compound is orally active.
- It is a metabolite of furazolidone.
- It is an indicator of furazolidone residues in vivo.
- The compound is orally active.
- It inhibits monoamine oxidase (MAO) via its metabolite in rats' brain and liver.
- It increases levels of monoamine neurotransmitters like norepinephrine and dopamine in the brain.
- It lowers blood pressure in renal hypertensive rats.
Medchemexpress LLC 3-Amino-2-oxazolidinone (AOZ) | 80-65-9 | 98.0% | 102.09 | 50 MG
3-Amino-2-oxazolidinone (AOZ) is a metabolite of Furazolidone and is used as an indicator for furazolidone residues in vivo. This orally active product inhibits monoamine oxidase (MAO) through its metabolite in rat brain and liver, increasing levels of monoamine neurotransmitters like norepinephrine and dopamine, and lowering blood pressure in renal hypertensive rats.
- Used as an indicator for furazolidone residues
- Orally active
- Increases levels of monoamine neurotransmitters
- Lowers blood pressure in renal hypertensive rats
Medchemexpress LLC 3-Amino-2-oxazolidinone (AOZ) | 80-65-9 | 98.0% | 102.09 | 10 MG
3-Amino-2-oxazolidinone (AOZ) is a metabolite of Furazolidone. It is used as an indicator for furazolidone residues in vivo and is orally active. In animal models, it has been shown to inhibit monoamine oxidase (MAO) via its metabolite in rat brain and liver, increase monoamine neurotransmitter levels (e.g., norepinephrine and dopamine) in the brain, and lower blood pressure in renal hypertensive rats.
- Used as an indicator for furazolidone residues in vivo.
- Orally active.
- Inhibits monoamine oxidase (MAO).
- Increases monoamine neurotransmitter levels in the brain.
- Lowers blood pressure in renal hypertensive rats.
Medchemexpress LLC 3-amino-2-oxazolidinone (AOZ) | 80-65-9 | 98.0% | 102.09 | 25 MG
3-Amino-2-oxazolidinone (AOZ) is a metabolite of Furazolidone. It is used as an indicator for furazolidone residues in vivo and is orally active. Research indicates it inhibits monoamine oxidase (MAO) through its metabolite in rat brain and liver, increasing monoamine neurotransmitter levels like norepinephrine and dopamine, and lowering blood pressure in renal hypertensive rats. It has been observed to reduce blood pressure in renal hypertensive rat models by 60% at a dosage of 30 mg/kg administered orally once daily for 10 days. This product is for research use only and not sold to patients.
- Metabolite of furazolidone
- Used as an indicator for furazolidone residues in vivo
- Orally active
- Inhibits monoamine oxidase (MAO)
- Increases monoamine neurotransmitter levels
- Lowers blood pressure in renal hypertensive rats
- For research use only
Medchemexpress LLC 9-Dihydro-13-acetylbaccatin III (9-DHAB III) | 142203-65-4 | 99.6% | C33H42O12 | 100 MG
9-Dihydro-13-acetylbaccatin III (9-DHAB III) is an intermediate for the preparation of paclitaxel analogs. It has demonstrated antiproliferative activity against mouse P388 cells with an IC50 of 20 μg/mL, as determined by an MTT assay.
- Purity of 99.6%
- Molecular weight: 630.68
- Chemical formula: C33H42O12
- Appearance: White to off-white solid
- Classified as a terpenoid and diterpenoid
- Derived from Taxus chinensis plants
- Soluble in DMSO at 20 mg/mL
- Powder storage: -20°C for 3 years, 4°C for 2 years
- In solvent storage: -80°C for 2 years, -20°C for 1 year
Medchemexpress LLC 9-Dihydro-13-acetylbaccatin III (9-DHAB III) | 142203-65-4 | 99.6% | C33H42O12 | 1 ML
9-Dihydro-13-acetylbaccatin III (9-DHAB III) is an intermediate used in the preparation of paclitaxel analogs. This compound exhibits antiproliferative activity against mouse P388 cells, as determined by MTT assay.
- Intermediate for paclitaxel analog preparation
- Purity of 99.6%
- White to off-white solid appearance
- Classified as terpenoids and diterpenoids
- Derived from Taxus chinensis plants
- Demonstrates antiproliferative activity against P388 cells
- Powder stable for up to 3 years at -20°C or 2 years at 4°C
- Solution stable for up to 2 years at -80°C or 1 year at -20°C
- Soluble in DMSO at 20 mg/mL
Medchemexpress LLC 3,4-dihydro-6,7-isoquinolinediol | 4602-83-9 | MFCD00143490 | 98.7% | 163.17 g·mol⁻¹ | C9H9NO2 | 50 MG
3,4-Dihydro-6,7-isoquinolinediol is a small-molecule research compound (C9H9NO2) used in analytical and biochemical studies. It is supplied with high reported purity and has associated analytical and safety documentation for laboratory handling and storage.
- High purity: 98.7%.
- Molecular weight: 163.17 g·mol⁻¹.
- Chemical formula: C9H9NO2.
- CAS number: 4602-83-9.
- Available in milligram quantities (e.g., 10 mg-100 mg) for research use.
- Storage recommendations: store at 4°C under nitrogen; in solvent: -80°C (6 months), -20°C (1 month).
- Certificate of analysis and safety data sheet available.
Medchemexpress LLC EHNA hydrochloride | 58337-38-5 | MFCD00151066 | 99.7% | 313.83 g/mol | C14H24ClN5O | 1 ML
EHNA hydrochloride is the hydrochloride salt of erythro-9-(2-hydroxy-3-nonyl)adenine, a selective phosphodiesterase (PDE) inhibitor and adenosine deaminase inhibitor used in biochemical research. It is provided as a 10 mM solution in DMSO for direct use in in vitro assays and signaling studies.
- High purity: 99.67%.
- Molecular weight 313.83 g/mol; formula C14H24ClN5O.
- Supplied as a 10 mM solution in DMSO (1 mL).
- Solubility: readily soluble in DMSO and water under recommended conditions.
- Storage: solid at -20°C; solution recommended at -80°C for long-term storage.
- For research use only; not for human or diagnostic use.
Medchemexpress LLC 3,4-dihydro-6,7-isoquinolinediol | 4602-83-9 | MFCD00143490 | 98.7% | 163.17 g/mol | C9H9NO2 | 100 MG
3,4-Dihydro-6,7-isoquinolinediol is a small-molecule research compound used in biochemical and pharmacological studies and reported to act as a β2-adrenergic receptor agonist with measurable cellular activity. It is supplied as a solid in milligram-scale vials for laboratory use and includes recommended storage and solvent stability conditions for research handling.
- Molecular formula: C9H9NO2.
- Molecular weight: 163.17 g/mol.
- Cas number: 4602-83-9.
- Purity: 98.7% (reported).
- Available package sizes: 10 MG, 25 MG, 50 MG, 100 MG, 200 MG, 500 MG.
- Storage: store at 4°C under nitrogen; in solvent: -80°C (6 months) or -20°C (1 month) when under nitrogen.
- Intended use: for biochemical and pharmacological research only, not for human use.
Medchemexpress LLC Flupentixol dihydrochloride | 2413-38-9 | 98.5% | 507.44 | C23H27Cl2F3N2OS | 10 MG
Flupentixol dihydrochloride is the dihydrochloride salt of flupentixol, provided as a research-grade solid for laboratory and analytical applications. Typical purity is 98.52%, with batch-specific certificates reported up to 99.73%. The compound functions as a dopamine D1/D2 receptor antagonist and has reported PI3Kα inhibitory activity.
- Chemical form: dihydrochloride salt, solid.
- Pharmacology: D1/D2 dopamine receptor antagonist and reported PI3Kα inhibitor.
- Purity: typically 98.5%; batch-specific purity may be higher.
- Appearance: solid.
- Chemical identifiers: CAS 2413-38-9; molecular weight 507.44; formula C23H27Cl2F3N2OS.
- Storage: store sealed at 4°C, protect from moisture and light; in solution store at -80°C (up to 6 months) or -20°C (up to 1 month).
- Intended use: research and analytical applications, not for human or therapeutic use.